Xylem Inc. lowered its 2026 adjusted EPS outlook to $5.45 from a previous floor of $5.55, citing project delays and cautious customer spending. This adjustment caused a share price drop and triggered an investigation by Levi & Korsinsky into possible securities law violations related to misleading earnings forecasts. Shareholders who suffered losses from this announcement may be eligible to recover damages and are encouraged to submit their information for a free case evaluation. The investigation focuses on whether Xylem misled investors before the October 27, 2026 disclosure, potentially causing inflated stock purchases.
Despite the investigation news, Xylem Inc. shares are up 3.16% on Pluang, trading at USD 93.63 as of Oct 30, 2026 21:22 WIB. The stock shows strong buying interest with 86% of orders as buys and a market cap of $20.81 billion at that time.
Xylem's stock has fallen over 30% year-to-date after missing Q3 2026 revenue and EPS expectations. The company lowered its full-year 2026 guidance, projecting revenue of $8.95 billion and EPS between $5.40 and $5.45 due to project delays and weak sal...
Xylem Inc. reported third-quarter revenue of approximately $2.20 billion, missing Wall Street's estimate by about $80 million and falling short of its own projections. Adjusted earnings per share were $1.44, slightly below the consensus of $1.45. The...
